(Q40150463)

17 September 2017

Gamma interferon suppresses acute and chronic Trypanosoma cruzi infection in cyclosporin-treated mice (English)

1 reference

17 September 2017

0 references

McCabe R

1

1 reference

17 September 2017

Meagher S

series ordinal

2

1 reference

17 September 2017

Mullins B

series ordinal

3

1 reference

17 September 2017

language of work or name

English

0 references

publication date

1 May 1991

1 reference

17 September 2017

Infection and Immunity

1 reference

17 September 2017

59

1 reference

17 September 2017

5

1 reference

17 September 2017

1633-1638

1 reference

Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities

17 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Automated, quantitative cytopathic effect reduction assay for interferon

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Rapid, quantitative, semiautomated assay for virus-induced and immune human interferons

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Administration of recombinant interferon gamma to cancer patients enhances monocyte secretion of hydrogen peroxide

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Prevention by gamma interferon of fatal infection with Listeria monocytogenes in mice treated with cyclosporin A

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

The influence of cyclosporin A on cell-mediated immunity

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Killing in vitro of Trypanosoma cruzi by macrophages from mice immunized with T. cruzi or BCG, and absence of cross-immunity on challege in vivo

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Immunosuppression for Organ Grafting Observations on Cyclosporin A

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Tissue Tropism of Different Trypanosoma cruzi Strains

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Characterization of the Antiviral Activity Produced during Trypanosoma cruzi Infection and Protective Effects of Exogenous Interferon against Experimental Chagas' Disease

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Ketoconazole Inhibition of Intracellular Multiplication of Trypanosoma cruzi and Protection of Mice Against Lethal Infection with the Organism

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Ketoconazole promotes parasitological cure of mice infected with Trypanosoma cruzi.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Effects of intradermal gamma-interferon in cutaneous leishmaniasis.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Trypanosoma cruzi: explant organ cultures from mice with chronic Chagas' disease.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Exacerbation of Trypanosoma cruzi infection in mice treated with the immunoregulatory agent cyclosporin A.

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Interferon and Natural Killer Cells in Murine Chagas' Disease

2 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Increased Serum Levels of an Interferon-Like Activity during the Acute Period of Experimental Infection with Different Strains of Trypanosoma Cruzi *

2 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Induction of an Interferon-Like Inhibitor by Trypanosoma Cruzi Infection in Mice *

2 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

In vivo and in vitro effects of cyclosporin A on Trypanosoma cruzi

2 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Failure of ketoconazole to cure chronic murine Chagas' disease

2 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections

2 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=257895

Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy

2 December 2018

1 reference

12 December 2020

Effect of murine interferon gamma on murine toxoplasmosis

1 reference

12 December 2020

Failure of Trypanosoma cruzi to trigger the respiratory burst of activated macrophages. Mechanism for immune evasion and importance of oxygen-independent killing

1 reference

12 December 2020

Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis

1 reference

12 December 2020

Immunotherapy for parasitic disease

1 reference

12 December 2020

Cyclosporin A inhibits the delayed-type hypersensitivity reaction: impaired production of early pro-inflammatory mediator(s)

1 reference

12 December 2020

Marked disparity in incidence of bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 or interferon-gamma

1 reference

12 December 2020

10.1128/IAI.59.5.1633-1638.1991

Identifiers

DOI

0 references

1 reference

17 September 2017

PubMed publication ID

1902193

1 reference